title: Romidepsin and interferon gamma: a novel combination for refractory cutaneous T-cell lymphoma.
authors.affiliation: Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. sara.samimi@uphs.upenn.edu
authors.forename: Sara
authors.initials: S
authors.lastname: Samimi
authors.forename: Kelly
authors.initials: K
authors.lastname: Morrissey
authors.forename: Sasha
authors.initials: S
authors.lastname: Anshelevich
authors.forename: Katherine
authors.initials: K
authors.lastname: Evans
authors.forename: Jennifer
authors.initials: J
authors.lastname: Gardner
authors.forename: Amy
authors.initials: A
authors.lastname: Musiek
authors.forename: Carmela
authors.initials: C
authors.lastname: Vittorio
authors.forename: Alain
authors.initials: A
authors.lastname: Rook
authors.forename: Ellen
authors.initials: E
authors.lastname: Kim
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D047630:Depsipeptides / Q000008:administration & dosage; D006801:Humans; D007371:Interferon-gamma / Q000008:administration & dosage; D016410:Lymphoma, T-Cell, Cutaneous / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012878:Skin Neoplasms / Q000188:drug therapy*
chemical_list: D047630:Depsipeptides; D007371:Interferon-gamma; C087123:romidepsin